Tilray Brands, Inc.

TLRY

US88688T2096

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 04:00:00 2026-02-13 pm EST			5-day change	1st Jan Change
7.510 ^USD	+0.27%		-0.92%	-16.83%

Feb. 12	Tilray expands UK pharmaceutical access through strategic agreement with Smartway Pharmaceuticals	RE
Feb. 12	Tilray expands UK pharmaceutical access through strategic agreement with Smartway Pharmaceuticals	RE

Tilray Brands Brief: Delivering Record Q2 Fiscal 2026 Net Revenue of US$218 Million

Published on 01/08/2026 at 04:06 pm EST

MT Newswires

Latest news about Tilray Brands, Inc.

Feb. 12	Tilray expands UK pharmaceutical access through strategic agreement with Smartway Pharmaceuticals	RE
Feb. 12	Tilray expands UK pharmaceutical access through strategic agreement with Smartway Pharmaceuticals	RE
Feb. 12	Tilray Brands European Unit Signs UK Distribution Agreement With Smartway Pharmaceuticals	MT
Feb. 12	Tilray Brands Expands UK Pharmaceutical Access	MT
Feb. 12	Tilray Brief: Expanding UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals	MT
Jan. 22	Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio	CI
Jan. 22	Tilray Solidifies Italian Market Presence With Launch of Tilray Medical Italia	MT
Jan. 22	Tilray Brands Unit Launches Tilray Medical Italia	MT
Jan. 22	Tilray Medical boosts Italy presence, launches Tilray Medical Italia, expands medical Cannabis portfolio	RE
Jan. 22	Tilray Medical Brief: Strengthening Italian Market Presence with Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio	MT
Jan. 09	TSX futures dip ahead of key jobs data, US top court's ruling on tariffs	RE
Jan. 08	Tilray Brands, Inc., Q2 2026 Earnings Call, Jan 08, 2026
Jan. 08	Tilray Brands Fiscal Q2 Loss Narrows, Revenue Rises	MT
Jan. 08	Tilray's Up 7.2% After Hours as Its Fiscal Second-Quarter Adjusted Loss Narrows on Higher Revenue	MT
Jan. 08	Tilray Brands, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2025	CI

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.

Employees

2,842

Sector

Pharmaceuticals

Calendar

Apr. 13 - Q3 2026 Earnings Release (Projected)

More about the company